Ashton Giammona
Neurology · Port Royal, SCNPI 1093609174
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations.
Across 46 payments — averaging $28.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$139
- Lundbeck LLC$111
- AstraZeneca$90
- TG Therapeutics, Inc.$85
- Takeda Pharmaceuticals U.S.A., Inc.$73
- Eisai Inc.$71
- plus $721 from 19 others
What the payments were for
- Food & beverage$1,290100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 3 | $139 |
| Lundbeck LLC | 4 | $111 |
| AstraZeneca | 4 | $90 |
| TG Therapeutics, Inc. | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $73 |
| Eisai Inc. | 3 | $71 |
| Harmony Biosciences LLC | 2 | $64 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
| AbbVie | 2 | $63 |
| Argenx US, Inc. | 2 | $63 |
| Averitas Pharma Inc. | 2 | $62 |
| Genentech USA, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| C2n Diagnostics, LLC | 2 | $37 |
| SK Life Science, Inc. | 1 | $30 |
| Biogen | 1 | $30 |
| Amgen | 1 | $28 |
| Tanabe Pharma America, Inc. | 1 | $25 |
| Insightec,inc | 1 | $25 |
| Bristol Myers Squibb | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Pfizer | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Sanofi | 1 | $15 |
How this compares
$1,290 in reported general payments places this provider in the 55th percentile of 270 neurology providers in South Carolina.
Other neurology in Port Royal
- Paul MazzeoPort Royal$49K
- John BakerSumter$779K
- Robert CarlileSummerville$428K
- Mary HughesGreenville$404K
- Jose CardenasAiken$216K
- Fredy RevillaGreenville$208K
- Robert AdamsCharleston$204K
- Thomas HughesMt. Pleasant$102K
- Kathleen WoschkolupGreenville$97K
- Sarah BreevoortCharleston$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.